ConductScience.org, home

Library / Trials

The Role of Anchoring and Distraction in the Effectiveness of Mindfulness on Reducing Emotional Reactivity

NCT06876220, Not applicable, Completed, The University of Hong Kong

Trial 10

As registered on ClinicalTrials.gov, in the graph's capture of the registry.

FieldValueSource
TitleThe Role of Anchoring and Distraction in the Effectiveness of Mindfulness on Reducing Emotional ReactivityClinicalTrials.gov
NCT numberNCT06876220ClinicalTrials.gov
StatusCompletedClinicalTrials.gov
PhasesNot applicableClinicalTrials.gov
Enrollment42 participants, actualClinicalTrials.gov
Lead sponsorThe University of Hong KongClinicalTrials.gov
ConditionsMental Health Issue, Emotional AdjustmentClinicalTrials.gov
InterventionsMindfulness-based Cognitive Therapy for Life (MBCT-L)ClinicalTrials.gov
First posted2025-03-14ClinicalTrials.gov
Last updated2025-07-24ClinicalTrials.gov

Registered outcomes 7

Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.

ListOutcomeTime frameDescriptionSource
PrimaryBrain activation during the emotion care/regulation taskBaseline (2 weeks before the intervention), Post-intervention (14-16 weeks after baseline)BOLD signal contrast when the participants performing an emotion counting Stroop task.ClinicalTrials.gov
PrimaryReaction time during the emotion care/regulation taskBaseline (2 weeks before the intervention), Post-intervention (14-16 weeks after baseline)Reaction time of the correct response in the emotion counting Stroop task.ClinicalTrials.gov
PrimaryAccuracy during the emotion care/regulation taskBaseline (2 weeks before the intervention), Post-intervention (14-16 weeks after baseline)Accuracy of the emotion counting Stroop task.ClinicalTrials.gov
PrimaryMindfulnessBaseline (2 weeks before the intervention), Post-intervention (14-16 weeks after baseline), Follow-up (22-24 weeks after baseline)
The mean score of Cognitive and Affective Mindfulness Scale-Revised (CAMS-R, Feldman, Hayes, Kumar, Greeson, \& Laurenceau, 2007) is a self-report 5-point Likert scale measuring individual differences in mindfulness that includes 12 items. The mean score ranged from 1 to 5. A higher score means a higher level of mindfulness, i.e. an expected outcome from an effective mindfulness intervention.
ClinicalTrials.gov
PrimaryPsychological well-beingBaseline (2 weeks before the intervention), Post-intervention (14-16 weeks after baseline), Follow-up (22-24 weeks after baseline)
The mean score of Psychological Well-being Scale (PWBS; Ryff et al., 1995) includes 18 items measuring 6 aspects of wellbeing and happiness: autonomy, environmental mastery, personal growth, positive relations with others, purpose in life, and self-acceptance. Participants used a 5-point Likert scale, ranging from 1 = highly disagree to 5 = highly agree, to rate the 18 statements. The mean score ranged from 1 to 5. A higher score means a higher level of psychological well-being, i.e. an expected outcome from an effective mindfulness intervention.
ClinicalTrials.gov
PrimaryUse of distraction as a emotion care/regulation strategyBaseline (2 weeks before the intervention), Post-intervention (14-16 weeks after baseline), Follow-up (22-24 weeks after baseline)
The mean scores of five items of the self-developed scale to assess the use of distraction and its connection to attentional deployment with a pilot test. Participants used a 5-point Likert scale, ranging from 1 = never to 5 = always, to rate the five statements. The mean score ranged from 1 to 5. A higher score indicates a greater tendency to employ distraction as an emotion regulation strategy. It's important to note that the score only reflects the habitual usage of this strategy and does not imply a better or worse outcome.
ClinicalTrials.gov
PrimaryUse of anchoring as a emotion care/regulation strategyBaseline (2 weeks before the intervention), Post-intervention (14-16 weeks after baseline), Follow-up (22-24 weeks after baseline)
The mean score of five items of the self-developed scale to assess the use of anchoring with a pilot test. Participants used a 5-point Likert scale, ranging from 1 = never to 5 = always, to rate the five statements. The mean score ranged from 1 to 5. A higher score indicates a greater tendency to employ distraction as an emotion regulation strategy. It's important to note that the score only reflects the habitual usage of this strategy and does not imply a better or worse outcome.
ClinicalTrials.gov

Outcomes 0

Each outcome the trial posted results for, in ClinicalTrials.gov's words.

TypeOutcomeTime framePopulationUnitsMeasured asSource

Results by group 0

Each measurement the trial posted, group by group, in the words and numbers it posted.

OutcomeGroupCategoryValueSpreadUnitsSource

Participant flow 0

How many started, completed or left each group, period by period.

PeriodMilestoneGroupParticipantsUnits countedSource

Adverse events 0

Each adverse event the trial posted, group by group: the participants affected out of those at risk.

TypeEventOrgan systemGroupAffectedAt riskEventsSource

Adverse event totals 0

The totals the trial posted for each group.

TotalGroupAffectedAt riskSource

Papers 0

The papers the trial lists on ClinicalTrials.gov.

PMIDListed asSource

Grants 0

The grants NIH RePORTER links to the trial, newest funded first: NIH's, and some of AHRQ's, CDC's, FDA's and VA's. Each shows its title, principal investigators, organization and funder in its newest year.

ProjectTitlePrincipal investigatorsOrganizationFunderFiscal yearsSource

Trial comparisons 0

Comparisons of the trial's two groups, calculated by ConductScience from the counts it posted.

ComparisonSource

Tests 1

The ConductCognition tests this trial's registered outcomes name, as ScienceGraph matched them in trial-tests-2026-11-12-0.2.1.

TestNamed asSource
Stroop Color-Word TestPrimary outcomeConductCognition

Source 5

FieldValueSource
Releasetrials-2026-11-12-0.4.0ClinicalTrials.gov
Release manifest SHA-2560f4a8d8c48aee2a7573ae0fa94ecbeab70c1adbe449bbc95c424bc7d3e97b9d4ClinicalTrials.gov
Registry capture2026-11-12ClinicalTrials.gov
Results copy, AACT2026-03-23ClinicalTrials.gov
NIH clinical studies file2026-11-13ClinicalTrials.gov

The same record as JSON

Release trials-2026-11-12-0.4.0

ClinicalTrials.gov's posted results, through CTTI's AACT: ClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299 ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

ClinicalTrials.gov: none stated ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

NIH RePORTER's clinical studies and project files: Public domain (NIH RePORTER)